UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000026497 |
|---|---|
| Receipt number | R000030362 |
| Scientific Title | Phase I trial of nivolumab in pediatric patients with malignant solid tumors or Hodgkin lymphoma |
| Date of disclosure of the study information | 2017/03/10 |
| Last modified on | 2022/10/31 12:51:02 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2017/03/10 12:44:55 | ||
| 2 | Update | 2017/04/03 14:02:24 | Recruitment status |
|
| 3 | Update | 2019/02/27 17:42:41 | Last name of contact person Last name of contact person Division name Division name |
|
| 4 | Update | 2019/10/18 10:57:40 | UMIN ID3 |
|
| 5 | Update | 2019/10/18 11:48:37 | Recruitment status Date of IRB Last follow-up date |
|
| 6 | Update | 2021/03/23 14:02:37 | Last follow-up date |
|
| 7 | Update | 2021/10/08 13:36:05 | Number of participants that the trial has enrolled |
|
| 8 | Update | 2021/10/08 13:42:13 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Organization Organization Address Address Tel |
|
| 9 | Update | 2021/10/08 14:01:28 | Email Email1 |
|
| 10 | Update | 2021/10/13 15:30:34 | Email1 |
|
| 11 | Update | 2022/10/31 12:51:02 | Recruitment status |
